Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled TrialStefan Bielack, Mark L. Bernstein, Gordana Jovic et al.|Journal of Clinical Oncology|2015Cited by 419
miRISC inhibition causes mitotic defects and synergizes with genotoxic agents in cancersMinsi Zhang, Gaspare La Rocca, Ziqi Jiao et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 0